Literature DB >> 435499

Qualitative and quantitative aspects of intercalator-induced DNA strand breaks.

W E Ross, D Glaubiger, K W Kohn.   

Abstract

The intercalating agents, adriamycin and ellipticine, were previously found to produce DNA strand breaks associated with DNA-protein crosslinks in mouse leukemia L1210 cells. The current work explores the nature of the agents that produce this effect and the quantitative relationship between the breaks and crosslinks. The protein-associated DNA breaks were produced by a wide variety of intercalators in addition to the above-mentioned compounds: actinomycin D, daunoycin, ethidium and lucanthone (miracil D). Treatment with several drugs that bind to DNA without intercalation, or that inhibit DNA synthesis without binding to DNA, did not cause DNA breaks. The strand break and crosslink frequencies were quantitated by means of alkaline elution methods. The strand break and crosslink frequencies were found to be within a factor of 2 of each other over a range of concentrations of adriamycin and ellipticine. It is proposed that intercalation-induced distortion of the DNA helix leads to strand scission by a nuclease which becomes bound to one terminus of the break so as to form a DNA-protein crosslink.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 435499     DOI: 10.1016/0005-2787(79)90124-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  31 in total

1.  A comparison of the effects of DNA-damaging agents and biotic elicitors on the induction of plant defense genes, nuclear distortion, and cell death.

Authors:  J J Choi; S J Klosterman; L A Hadwiger
Journal:  Plant Physiol       Date:  2001-02       Impact factor: 8.340

Review 2.  Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Authors:  J M Henwood; R N Brogden
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 3.  Topoisomerases, new targets in cancer chemotherapy.

Authors:  J G Zijlstra; S de Jong; E G de Vries; N H Mulder
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

4.  Drosophila topoisomerase II double-strand DNA cleavage: analysis of DNA sequence homology at the cleavage site.

Authors:  M Sander; T S Hsieh
Journal:  Nucleic Acids Res       Date:  1985-02-25       Impact factor: 16.971

5.  Cooperative binding of m-AMSA to nucleic acids.

Authors:  R H Elmore; R M Wadkins; D E Graves
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

6.  Intracellular DNA damage produced by a series of diacridines.

Authors:  I A Roos; L P Wakelin; S J Henry
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

Review 7.  Topoisomerase inhibitors. A review of their therapeutic potential in cancer.

Authors:  B K Sinha
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

8.  Survival of rat mammary tumor cell clones and DNA strand damage following adriamycin treatment.

Authors:  D P Evans; R E Meyn; S P Tomasovic
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

Authors:  E M Nelson; K M Tewey; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

10.  Evidence for lack of mitochondrial DNA repair following cis-dichlorodiammineplatinum treatment.

Authors:  G Singh; E Maniccia-Bozzo
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.